1986
DOI: 10.1136/jmg.23.2.155
|View full text |Cite
|
Sign up to set email alerts
|

The relationship between the acetylator and the sparteine hydroxylation polymorphisms.

Abstract: SUMMARY Thirty-eight healthy white British Caucasian subjects were hydroxylator phenotyped with sparteine and acetylator phenotyped with sulphadimidine. The results showed that there was no significant difference in the mean sparteine metabolic ratio between eight rapid acetylator extensive hydroxylators and 27 slow acetylator extensive hydroxylators. ResultsThe acetylator phenotyping information is shown in

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0
1

Year Published

1987
1987
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 16 publications
0
3
0
1
Order By: Relevance
“…N ‐acetylation polymorphism causes interindividual variations in the biotransformation of various drugs, procarcinogens, and other xenobiotics with a primary aromatic or hydrazine structure [5]. The drugs sulfadimidine, hydralazine, dapsone, procainamide, sulfapyridine, nitrazepam, and caffeine are metabolized by NAT enzyme [6]. Hereditary differences in N ‐acetylation activity among individuals and in populations of diverse racio‐geographic origin, have led to the phenotype classification of humans as rapid and slow acetylators [7].…”
Section: Introductionmentioning
confidence: 99%
“…N ‐acetylation polymorphism causes interindividual variations in the biotransformation of various drugs, procarcinogens, and other xenobiotics with a primary aromatic or hydrazine structure [5]. The drugs sulfadimidine, hydralazine, dapsone, procainamide, sulfapyridine, nitrazepam, and caffeine are metabolized by NAT enzyme [6]. Hereditary differences in N ‐acetylation activity among individuals and in populations of diverse racio‐geographic origin, have led to the phenotype classification of humans as rapid and slow acetylators [7].…”
Section: Introductionmentioning
confidence: 99%
“…Es una enzima detoxificante expresada principalmente en el hígado. Acetiliza varias drogas actualmente en el mercado, incluyendo, INH, sulfadmidina, hidralazina, dapsona, procaina amida, sulfapiridina y nitrazepam (23) . El gen NAT2, el cual contiene un solo exon de 870 pares de bases, codifica 290 aminoácidos, y se conocen 16 polimorfismos de nucleótido único (SNP) y una deleción de un par de bases, los cuales han sido asociados con una alteración en la actividad metabólica (24)(25)(26) .…”
Section: Nat2unclassified
“…It is implicated in the modification of risk factors in the development of malignancies involving the urinary bladder, colorectal region, breast, prostate, lungs and the head and neck region. It is also shown to be involved in the development of Alzheimer's disease, schizophrenia, diabetes, cataract and parkinsonism 1 2 3 .…”
mentioning
confidence: 99%
“…A Japanese study also reported good concordance between NAT2 genotype and metabolism of INH in patients with tuberculosis 11 . However, in patients with AIDS there was discordance between acetylator genotype and phenotype of NAT 2 as measured by caffeine as a probe drug 12 .…”
mentioning
confidence: 99%